177 related articles for article (PubMed ID: 34238184)
21. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
[TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
23. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
[TBL] [Abstract][Full Text] [Related]
24. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
25. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
[TBL] [Abstract][Full Text] [Related]
26. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
27. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
[TBL] [Abstract][Full Text] [Related]
28. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier.
Poller B; Drewe J; Krähenbühl S; Huwyler J; Gutmann H
Cell Mol Neurobiol; 2010 Jan; 30(1):63-70. PubMed ID: 19629677
[TBL] [Abstract][Full Text] [Related]
29. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
[TBL] [Abstract][Full Text] [Related]
30. Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats.
Xu P; Ling ZL; Zhang J; Li Y; Shu N; Zhong ZY; Chen Y; Di XY; Wang ZJ; Liu L; Liu XD
Acta Pharmacol Sin; 2016 Aug; 37(8):1129-40. PubMed ID: 27180978
[TBL] [Abstract][Full Text] [Related]
31. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
32. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
33. Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.
Minocha M; Khurana V; Qin B; Pal D; Mitra AK
Int J Pharm; 2012 Sep; 434(1-2):306-14. PubMed ID: 22633931
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier.
Bousquet L; Roucairol C; Hembury A; Nevers MC; Creminon C; Farinotti R; Mabondzo A
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1147-54. PubMed ID: 18729774
[TBL] [Abstract][Full Text] [Related]
35. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
[TBL] [Abstract][Full Text] [Related]
36. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Blanc Mettral J; Faller N; Cruchon S; Sottas L; Buclin T; Schild L; Choong E; Nahimana A; Decosterd LA
Drug Metab Lett; 2019; 13(2):102-110. PubMed ID: 30734690
[TBL] [Abstract][Full Text] [Related]
37. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.
Miller DW; Hinton M; Chen F
Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715
[TBL] [Abstract][Full Text] [Related]
39. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
Hoque MT; Shah A; More V; Miller DS; Bendayan R
J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
[TBL] [Abstract][Full Text] [Related]
40. Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study.
Conti A; Geffroy F; Kamimura HAS; Novell A; Tournier N; Mériaux S; Larrat B
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
